Table 3.
Specific treatments | Drug/drug class causing ADR | Clinical effect of treatment | Clinical context |
---|---|---|---|
Naloxone | Opioids | Antidote for opioid toxicity | Widely used for treatment of overdosage with opioids in a non-medical setting and reversal of postoperative respiratory depression |
Icatibant | ACE inhibitors | Treatment for life-threatening angioedema affecting airway/head and neck | This selective bradykinin B2 receptor antagonist has proven to reduce the time to complete resolution of angioedema |
Idarucizumab | Dabigatran | Antidote for the reversal of direct oral thrombin inhibitor | Novel humanised monoclonal antibody fragment developed as specific reversal agent, promptly restoring dabigatran-prolonged coagulation parameters to baseline values |
Intravenous lipid emulsion (Intralipid®) | Local Anaesthetics (eg lidocaine) | Treatment for systemic toxicity from local anaesthetic agents (eg severe cardiotoxic effects) | Reduce adverse effects resulting from inadvertent local anaesthetic overdoses, intravascular injections, or rapid absorption effects from injections in highly vascular sites |
ACE = angiotensin-converting enzyme; ADR = adverse drug reaction